| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| TENOFOVIR (is an active metabolite)
| TENOFOVIR |
ANTIINFECTIVE | - | Cmax 0.578 MICROMOLAR (300 MILLIGRAM) F 25 PERCENT VD 84.5 LITER (65 KILOGRAM) PPB 7 PERCENT Cl 3.4 LITER / HOUR (EQN) HT 17 HOUR | HIV REVERSE TRANSCRIPTASE PDB 8BVS (CRYO-EM STRUCTURE OF RAT SLC22A6 BOUND TO TENOFOVIR) LIGAND CODE = TFO (link to the list of PDB complexes) Download experimental 3D coordinates of TFO with added hydrogens | Reverse transcriptase,RNaseH UNIPROT Q72547 pol more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| TENOFOVIR ALAFENAMIDE (has an active metabolite)
| TENOFOVIR ALAFENAMIDE |
ANTIINFECTIVES | ORAL | Cmax 0.33 MICROMOLAR Tmax 1 HOUR PPB 80 PERCENT HT 0.51 HOUR SOLUBILITY 4.7 MILLIGRAM / MILLILITER | HIV REVERSE TRANSCRIPTASE | Reverse transcriptase,RNaseH UNIPROT Q72547 pol more at DrugCentral | EMA | |||
